đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
This is a prospective, single center, single arm, open label study of zanub...
Status
Unknown
Location
Renji Hospital, Shanghai Jiaotong University School of Medicine
Start Date
2023-10-12
Trial ID
NCT06033820
Treatments Being Tested
An open-label, prospective Phase III clinical study to compare polatuzumab ...
Status
Completed
Location
UK Graz UniversitĂ€tsklinik fĂŒr Innere Medizin Klinische Abteilung fĂŒr HĂ€matologie
Start Date
2021-04-30
Trial ID
NCT04833114
Treatments Being Tested
To evaluate the efficacy and safety of Linperlisib combined with standard i...
Status
Recruiting
Location
Institute of Hematology & Blood Disease Hospital
Start Date
2024-05-28
Trial ID
NCT06489808
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
Veterans Affairs Medical Center - Palo Alto
Start Date
2006-09-26
Trial ID
NCT00274924
The overall purpose of the study is to determine if MEDI-551, when used in ...
Status
Completed
Location
Research Site
Start Date
2012-02-27
Trial ID
NCT01453205
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of GLS-010 ...
Status
Unknown
Location
Multiple Locations
Start Date
2022-09
Trial ID
NCT05518318
Treatments Being Tested
This study aims to evaluate the efficacy and safety of tafasitamab combined...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2026-01-01
Trial ID
NCT07621406
The Glo-BNHL trial is trying to find better medicines for children and youn...
Status
Recruiting
Location
The Children's Hospital at Westmead
Start Date
2024-05-02
Trial ID
NCT05991388
The purpose of this trial is to measure the safety and effectiveness of epc...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-11-03
Trial ID
NCT04663347
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of glofita...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2022-11-16
Trial ID
NCT05533775
Treatments Being Tested